Category Specific RSS

asx nti

Autism patient conditions improved after 12 weeks of treatment of Neurotech’s drug

Can you make autistic people less autistic? Neurotech International (ASX: NTI) believes so based on data published from their Phase…

1 year ago

Clinical trial reveals promising outcomes for children with paediatric autoimmune neuropsychiatric disorders

PANDAS and PANS are debilitating conditions characterised by distressing symptoms, ranging from rage to signs of obsessive compulsive disorder.

2 years ago

Neurotech applies for ethics approval to trial cannabis as a treatment for Rett Syndrome

About one in 9,000 females in Australia are diagnosed with Rett Syndrome at birth. In the US, about 15,000 girls…

2 years ago

Neurotech reports clinical trial results for world first Autism Spectrum Disorder drug

Autism Spectrum Disorder (ASD) affects 1 in 150 Australians. Boys are 4 times more likely to have it than girls,…

3 years ago